tiprankstipranks
Trending News
More News >
Renascience Inc. (JP:4889)
:4889
Japanese Market
Advertisement

Renascience Inc. (4889) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Renascience Inc. has a market cap or net worth of ¥24.98B. The enterprise value is ¥21.37B.
Market Cap¥24.98B
Enterprise Value¥21.37B

Share Statistics

Renascience Inc. has 12,711,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,711,700
Owned by Insiders
Owned by Institutions

Financial Efficiency

Renascience Inc.’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is -8.20%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)-8.20%
Return on Capital Employed (ROCE)-0.10
Revenue Per Employee33.17M
Profits Per Employee28.36M
Employee Count4
Asset Turnover0.07
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Renascience Inc. is 385.0. Renascience Inc.’s PEG ratio is ―.
PE Ratio385.0
PS Ratio
PB Ratio
Price to Fair Value7.74
Price to FCF
Price to Operating Cash Flow0.00
PEG Ratio

Income Statement

In the last 12 months, Renascience Inc. had revenue of 132.69M and earned 113.43M in profits. Earnings per share was 8.92.
Revenue132.69M
Gross Profit128.95M
Operating Income-178.83M
Pretax Income143.76M
Net Income113.43M
EBITDA143.82M
Earnings Per Share (EPS)8.92

Cash Flow

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00

Dividends & Yields

Renascience Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.37
52-Week Price Change412.80%
50-Day Moving Average2.54K
200-Day Moving Average1.43K
Relative Strength Index (RSI)29.18
Average Volume (3m)847.66K

Important Dates

Renascience Inc. upcoming earnings date is Nov 6, 2025, TBA (Confirmed).
Last Earnings DateAug 13, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend Date

Financial Position

Renascience Inc. as a current ratio of 12.38, with Debt / Equity ratio of 0.00%
Current Ratio12.38
Quick Ratio12.38
Debt to Market Cap0.00
Net Debt to EBITDA-12.51
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Renascience Inc. has paid 30.34M in taxes.
Income Tax30.34M
Effective Tax Rate0.21

Enterprise Valuation

Renascience Inc. EV to EBITDA ratio is 80.11, with an EV/FCF ratio of -65.04.
EV to Sales86.83
EV to EBITDA80.11
EV to Free Cash Flow-65.04
EV to Operating Cash Flow-65.34

Balance Sheet

Renascience Inc. has ¥1.80B in cash and marketable securities with ¥0.00 in debt, giving a net cash position of -¥1.80B billion.
Cash & Marketable Securities¥1.80B
Total Debt¥0.00
Net Cash-¥1.80B
Net Cash Per Share-¥141.59
Tangible Book Value Per Share¥135.32

Margins

Gross margin is 96.94%, with operating margin of -134.77%, and net profit margin of 85.48%.
Gross Margin96.94%
Operating Margin-134.77%
Pretax Margin108.34%
Net Profit Margin85.48%
EBITDA Margin108.39%
EBIT Margin108.34%

Analyst Forecast

The average price target for Renascience Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast-27.00%
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score51
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis